Moderna, inc. (MRNA) 2025Q4 financial report shows net profit of -826M USD, with a YoY growth rate of 26.25%, clearly higher than last year, showing strong profit momentum and good management efficiency. It is recommended to monitor revenue, cash flow, and industry trends, and use Growin AI Value Analysis to seize growth opportunities. Overall, the company has shown a solid growth curve and future performance is worth watching.